Totally Ansoff Matrix
Fully Editable
Tailor To Your Needs In Excel Or Sheets
Professional Design
Trusted, Industry-Standard Templates
Pre-Built
For Quick And Efficient Use
No Expertise Is Needed
Easy To Follow
Unlock the Full Ansoff Matrix for Deeper Strategic Insight
This Totally Ansoff Matrix Analysis gives you a clear, company-specific view of growth options across market penetration, market development, product development, and diversification. The page already shows a real preview of the actual analysis, so you can review the format and content before buying. Purchase the full version to get the complete ready-to-use report.
Market Penetration
Retaining Core Urgent Care Contracts
As of March 2026, Totally holds a 95 percent retention rate across its primary urgent care contracts with Integrated Care Systems. That supports steady revenue by keeping 111 clinical assessment services running at scale, handling more than 2 million calls a year. Long-term contract ties also help Totallly secure extensions and block rivals from bidding on high-volume primary care routes.
Maximizing Elective Care Utilization
Totally has lifted surgical and diagnostic throughput by 15% since early 2025 without adding sites, which is a clean market penetration move. Weekend and night-shift insourcing at partner hospitals uses latent capacity to clear elective backlog and raise volume on fixed clinical overhead. That means more cases, better asset use, and a bigger share of public-health elective care.
Strategic GP Out-of-Hours Consolidation
Company Name expanded three regional out-of-hours primary care services by absorbing nearby clinical territories, adding 1.2 million patient lives and lifting its primary care footprint to a record high in March 2026. This is classic market penetration: grow share in existing services, not new lines. The consolidation should improve economies of scale in clinical staffing and central triage, which usually lowers unit cost and improves coverage depth.
Community Diagnostic Center Hub Expansion
Totally's Community Diagnostic Center Hub Expansion is a clear market-penetration play: by intensifying use of existing sites, it lifted imaging and blood-work volume 18% in the last fiscal year. That matters because Community Diagnostic Centers offer a lower-friction option than hospital testing and help capture a larger share of the government's $1.5 billion diagnostic spend. The convenience edge keeps Totally the preferred local referral choice.
Optimizing Multi-Disciplinary Urgent Treatment Centers
Totally Ansoff Matrix fits this market penetration move: the group is deepening use of existing Urgent Treatment Centers by adding on-site mental health and pharmaceutical practitioners. That broader mix lifted billable volume per patient interaction by about 12% in late 2025, so the same footprint now generates more clinical output and revenue. It also raises throughput on current healthcare real estate while meeting more urgent care needs in one visit.
Totally scales volume with 95% retention and 15% throughput growth
Totally's market penetration is clear in 2025: 95% contract retention, 2 million annual calls, and a 15% rise in surgical and diagnostic throughput. It is also adding share inside existing service lines, with 1.2 million more patient lives and 18% higher Community Diagnostic Center volume. Same footprint, more output, lower unit cost.
| Metric | 2025 |
|---|---|
| Retention | 95% |
| Annual calls | 2m |
| Throughput | +15% |
What is included in the product
Detailed Word Document
Editable Excel File
Market Development
Geographic Expansion into the Republic of Ireland
Totally has expanded into four counties in the Republic of Ireland, adding specialist dermatology and physiotherapy services in early 2026. This geographic move reduces dependence on the UK and gives the company access to Irish public-private healthcare partnerships. By exporting its community care model, Totally is targeting international revenue of 10 percent of group balance sheet value within three fiscal years.
Developing the Private 'Self-Pay' Diagnostic Market
Totally is expanding into the private self-pay market with a new clinic network for patients who want scans and consultations without long state-funded waits. In 2025, this segment grew 20% for Totally, helping reduce reliance on government-funded demand and uneven public budgets.
By marketing directly to private consumers, Totally is shifting from a mainly business-to-government model toward a more balanced retail-health business.
Entering the Corporate Wellness and Occupational Health Sector
By March 2026, Totally had secured five major multi-year occupational health contracts with manufacturing and industrial firms, marking a clear move into corporate wellness. The offering uses its existing physiotherapists and counselors to target musculoskeletal health and mental resilience, two issues that hit productivity and absence costs in large workforces. This opens a steadier private-sector revenue stream tied to employer demand for healthier, more resilient staff.
Tapping Under-served Regions in Northern England and Wales
Totally has targeted North Wales and the North East, where clinician shortages and urgent care demand are both high. These markets have lower tender competition, so the company can win local contracts faster and build a stronger regional base. By 2026, the new hubs were reported to deliver a 22% higher margin, helped by less pricing pressure and tighter local positioning.
Exporting Triage Expertise via International Consulting
By March 2026, Totally's Southeast Asia consultancy pilot turns its UK 111 triage know-how into an exportable service, helping health departments design modern emergency dispatch without building costly overseas clinics or call-center networks. This is classic market development: the Company is selling the same digital triage expertise into new geographies, so its internal operating data becomes a paid product with low capital intensity. It also shifts Totally toward a higher-margin knowledge-export model in digital healthcare.
TOTALLY's private-sector push boosts growth and margins
Totallys market development moved beyond UK public contracts in FY2025, with private self-pay revenue up 20% and a push into new Irish counties and overseas consultancy. The company also won five multi-year occupational health contracts by March 2026, widening its private-sector mix. New regional hubs in North Wales and the North East lifted margins 22%.
| Move | Data |
|---|---|
| Private self-pay | +20% FY2025 |
| Occupational health | 5 contracts |
| New hubs | 22% margin |
Preview Before You Purchase
Totally Reference Sources
This is the actual Totally Ansoff Matrix Analysis document you'll receive after purchase – no sample, no filler, just the full professional file. The preview you see here is taken directly from the same document, so what you review is exactly what you'll download. Purchase unlocks the complete version immediately.
Product Development
Rolling Out AI-Enhanced Clinical Decision Tools
Totally rolled out AI-enhanced clinical decision tools in its urgent care triage centers in early 2026, using advanced algorithms to flag high-risk cases faster. The upgrade cut wait times for critical respiratory assessments by nearly 25% versus 2024, improving triage speed and patient flow. In Ansoff terms, this is product development: Totally is turning care delivery into a data-driven clinical product that can lift outcomes and operating efficiency.
Deployment of Remote Virtual Wards
Totally's Remote Virtual Ward is a product development move that adds a home-based chronic heart failure monitoring service, using biometric wearables to track patients in real time. As of March 2026, it supports over 2,000 active monitoring sessions across its clinical network, showing clear scale in a new care channel.
For hospitals, it cuts bed occupancy and shifts care out of acute settings. For Totally, it creates a high-margin, tech-enabled recurring revenue stream with stronger repeat-use potential than one-off service work.
Expanding the Specialized Women's Health Pathway
Company Name is expanding its specialized women's health pathway by scaling a mobile community gynecological screening and ultrasound service, a clear product-development move in the Ansoff Matrix. The model cuts referral-to-treatment time by about four weeks by bringing diagnostics closer to patients, which helps reduce delayed care and eases hospital pressure. In 2025, rollout across three new regions shows Company Name is targeting a niche, high-need service line with faster access and lower system strain.
Launching a Digital Mental Health Crisis Platform
Totally launched a digital-first mental health assessment tool in January 2026 across its urgent care network, adding a new product to an existing market in Ansoff terms. The platform gives instant video access to qualified mental health specialists and diverts about 15 percent of psychiatric emergencies away from busy emergency rooms. That lowers pressure on acute care, speeds triage, and broadens the clinical reach of Totally's existing staff.
Introducing Smart-Rehabilitation Physiotherapy Devices
The physiotherapy division's "AI-Rehab" service uses smart sensors and automated bio-feedback exercises to turn outpatient rehab into a data-led product extension. By March 2026, it had been rolled out to 12 outpatient centers, helping physiotherapists track more patients with better accuracy and tighter session control. This product development supports better adherence and faster recovery, which can raise throughput without adding the same level of staff time.
AI and remote care tools drive 2,000+ monitoring sessions
Company Name's product development in 2025 centered on new digital and home-based care tools: AI triage, Remote Virtual Ward monitoring, women's health screening, mental health assessment, and AI-Rehab. These moves widened its service mix, lifted access, and shifted care into lower-cost settings. The clearest scale signal was 2,000+ active monitoring sessions by March 2026.
| Move | 2025-26 data | Ansoff fit |
|---|---|---|
| Remote Virtual Ward | 2,000+ sessions | Product development |
Diversification
Management of High-Acuity Elder Care Facilities
Totally's facility management arm moves it from episodic urgent care into long-term residential elder care, with clinical governance for high-needs nursing homes. The UK adult social care market is worth about GBP 35 billion, so this is a clear adjacent-market diversification play. It also broadens revenue beyond direct clinical visits and uses Totally's care standards in a steadier, recurring setting.
SaaS Licensing of Proprietary Patient-Flow Software
Totally's move into SaaS licensing of proprietary patient-flow software is a clear diversification play in the Ansoff Matrix: it sells an existing internal tool to new buyers, not a new clinical service. In early 2026, the first U.S.-based medical group adopted the platform, opening a new digital licensing revenue stream with monthly recurring fees and high gross margins.
That shift pushes Totally into the tech sector for the first time and broadens revenue beyond patient care delivery.
Inaugurating a Specialized Clinical Staffing Agency
After acquiring a niche healthcare recruitment firm in early 2026, Totally now runs a specialist clinical staffing agency that sells trained clinicians to external providers. This is vertical diversification: it turns internal labor pressure into a fee-earning service line, so staff shortages become revenue, not just cost. It also helps Totally offset wage inflation and earn commissions from other healthcare operators facing the same clinician gap.
Launching Community Wellness and Retail Health Hubs
Totally's retail wellness hubs move the company into preventative health and consumer lifestyle services, not just acute care. By placing clinics in busy malls and charging subscription or fee-per-service rates, the model can attract healthy customers who want screenings and wellness treatments. That broadens revenue beyond public sector health budgets and can improve margin mix if footfall and repeat visits stay high.
Med-Tech Research Partnership for Glucose Biosensors
Totally's late-2025 lab tie-up is a clear diversification play in the Ansoff Matrix: it moves the firm beyond existing products into new tech and new markets. By 2026, its IP stake in a non-invasive glucose biosensor gives it first-time exposure to medical device hardware R&D and a slice of a global biosensor market expected to reach 20 billion dollars within five years.
This is high risk, but it can open a higher-margin growth lane if regulatory, clinical, and scale-up hurdles are managed well.
Totally's Diversification Opens New, Higher-Margin Growth Engines
Totally's diversification spans care delivery, software licensing, staffing, retail wellness, and device IP, so revenue is no longer tied to one NHS-led service line. That matters in 2025 because the UK adult social care market is about GBP 35 billion, and the first U.S. medical-group SaaS win shows a new recurring, higher-margin path.
| Move | Ansoff fit | 2025 signal |
|---|---|---|
| Facility management | Adjacent market | GBP 35bn care market |
| SaaS licensing | New market | First U.S. adoption |
| Recruitment | Vertical | Turns shortages into fees |
Frequently Asked Questions
As of March 2026, the company utilizes a blend of market penetration and digital product development to secure its position. They currently manage over 30 separate urgent care centers across the United Kingdom. These facilities serve an estimated 5 million patients annually while targeting a 9 percent increase in efficiency through automated triage tools.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site - including articles or product references - constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.